Health Care/Hospital

Seegene to advance business in Latin America in the New Year

SEOUL, South Korea, Jan. 21, 2021 /PRNewswire/ -- South Korea's leading molecular diagnostics firm Seegene Inc. (KQ096530) said Wednesday that it is expanding its business inLatin America in the new year with a strong focus on its multiplex assay product. Seegene said it received an approval f...

2021-01-21 07:56 2341

ERBA Mannheim Launches 2nd Generation SARS-CoV-2 RT-PCR Assay with room temperature storage

LONDON, Jan. 21, 2021 /PRNewswire/ -- In response to the ongoing COVID-19 pandemic, Erba today launched the ErbaMDx SARS-CoV-2 RT-PCR Kit for detection of SARS-CoV-2. To overcome challenges in older COVID-19 molecular tests, Erba's Cambridge (UK)-based development team has carefully engineered a ...

2021-01-21 06:00 2574

Highlands Investments launches Africa's first contract cultivation offering - Canna-Tract™

Highlands Investments, a licensed cultivator of high-quality, low-cost medical grade cannabis, today launches Canna-Tract™ CAPE TOWN, South Africa, Jan. 21, 2021 /PRNewswire/ -- "Canna-Tract is Africa's first cannabis contract cultivation offering. Canna-Tract provides clients looking to grow co...

2021-01-21 00:03 2553

Merck Announces Update on the INTR@PID Clinical Program Including Lung 037 Study

DARMSTADT, Germany, Jan. 20, 2021 /PRNewswire/ -- Not intended for US-, Canada- or UK-based media Merck, a leading science and technology company, today announced an update on the Phase III INTR@PID Lung 037 study and the extensive INTR@PID clinical trial program for the potential first-in-class...

2021-01-20 23:35 2157

GS1 HK and Zenecom join hands to help local merchants seize trillions O2O opportunities in Mainland China's medical, healthcare and beauty markets

HONG KONG, Jan. 20, 2021 /PRNewswire/ -- GS1 Hong Kong (GS1 HK) and Zenecom International Group Co. Ltd (Zenecom) formally signed a strategic cooperation agreement to launch "HK Trusted Market + WJH" initiative. Capitalising on the cross-border "Big Health" e-commerce platform WJH, the programme ...

2021-01-20 20:56 3292

The 5th China Health Industry Development Forum Held in Panzhihua

PANZHIHUA, China, Jan. 20, 2021 /PRNewswire/ -- The 5th China Health Industry Development Forum, themed with "What Can the Health Industry Do for a Healthy China", was hosted in the Chinese city of Panzhihua onJanuary 18. At the forum that was organized by the Panzhihua Municipal People's Gover...

2021-01-20 20:02 1746

Clarivate Enhances Cortellis CMC Intelligence Platform with Addition of Comprehensive Biologics Content

LONDON, Jan. 20, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CCC), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the enhancement ofCortellis CMC Intelligence™, the world's only organized, timely and accurate source of Chemistry, ...

2021-01-20 16:15 6587

Jemincare initiates phase I clinical trial of anti-SARS-CoV-2 neutralizing antibody JMB2002

NANCHANG, China, Jan. 20, 2021 /PRNewswire/ -- On January 15, Jemincare Group, a Chinese pharmaceutical company, announced that it has initiated the phase I clinical trial of anti-SARS-CoV-2 neutralizing antibody (JMB2002). Preclinical studies of JMB2002 including pharmacology and toxicity were ...

2021-01-20 13:53 1613

Innodem Neurosciences Receives 6 Million US Dollars of Financing From Morningside Group

MONTREAL, Jan. 20, 2021 /PRNewswire/ -- Innodem Neurosciences, a Montreal-based company, has closed a Series A financing round led byMorningside Ventures to support the development and commercialization of its proprietary, patented, digital biomarking technology of neurodegenerative diseases such...

2021-01-20 12:00 2815

Genesis Medtech Collaborates with Penumbra to Expand Neurovascular Market in China

SINGAPORE, Jan. 20, 2021 /PRNewswire/ -- Genesis MedTech Group has reached a consensus to fully acquire Hua Medtech as part of its plans to set up a specialised neurovascular franchise, which has entered into a strategic cooperation with Penumbra, Inc., an NYSE listed, global healthcare company ...

2021-01-20 10:39 3669

Puhui Investments Announces Successful Initial Public Offering of Two Healthcare Industry Investments

BEIJING, Jan. 19, 2021 /PRNewswire/ -- Puhui Wealth Investment Management Co., Ltd. (Nasdaq: PHCF)("Puhui" or the "Company"), a third-party wealth management service provider with a focus on wealth management services for high net worth ("HNW") individuals and corporate clients as well as asset m...

2021-01-19 22:00 2855

Sirtex Medical announces collaboration update with OncoSec Medical

Collaboration provides Sirtex the right to co-promote OncoSec lead product candidate TAVO™ for the treatment of advanced melanoma WOBURN, Massachusetts, Jan. 19, 2021 /PRNewswire/ -- Sirtex Medical US Holdings, Inc. ("Sirtex"), a leading manufacturer of targeted cancer therapies, announced an ad...

2021-01-19 22:00 6266

Ortho Clinical Diagnostics Announces Launch of Initial Public Offering

RARITAN, N.J., Jan. 19, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics Holdings plc ("Ortho"), the world's largest pure-play in vitro diagnostics company dedicated to improving and saving lives through innovative laboratory testing and blood-typing solutions, today announced the launch of its in...

2021-01-19 21:57 1578

Medibio Granted CE Mark Approval for MEBsleep

MINNEAPOLIS, Jan. 19, 2021 /PRNewswire/ -- Medibio Limited (MEB or the Company )(ASX: MEB)(OTCPINK: MDBIF), is pleased to announce that it has received CE Mark approval for its sleep staging software, MEBsleep. MEBsleep is a software-only medical device that analyses Electroencephalogram (EEG) ...

2021-01-19 21:06 5311

CytoSorbents Announces Approval of CytoSorb® in Korea in Collaboration with Partner Fresenius Medical Care

CytoSorb now commercially available in Korea – one of the leading economies in Asia - to treat cytokine storm and other illnesses in critically-ill and cardiac surgery patients MONMOUTH JUNCTION, N.J., Jan. 19, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunot...

2021-01-19 20:08 6660

Virtual Visits and Connected Health Solutions Provide Better Care Delivery and Optimize ROI

Integrated solutions to offer greater value to stakeholders along the healthcare value chain, finds Frost & Sullivan SANTA CLARA, Calif., Jan. 19, 2021 /PRNewswire/ -- Telehealth's accelerated adoption during the COVID-19 pandemic has demonstrated the value that providers and payors can receive ...

2021-01-19 20:03 1531

Gracell Biotechnologies Receives IND Approval from China NMPA for GC019F, a FasTCAR-Enabled CAR-T Therapy for the Treatment of Relapsed or Refractory Adult B-ALL

SUZHOU and SHANGHAI, China, Jan. 19, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that the Nati...

2021-01-19 19:30 4200

Occlutech's Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Designation for Heart Failure (HF)

SCHAFFHAUSEN, Switzerland, Jan. 19, 2021 /PRNewswire/ -- Occlutech, a privately-held company, announced today that the U.S Food and Drug Administration (FDA) has granted the Company a Breakthrough Device designation for its first-in-class, implantable Atrial Flow Regulator (AFR) for heart failur...

2021-01-19 19:01 2955

InDevR Launches VaxArray Measles and Rubella Kit for Improved Vaccine Antigen Characterization

BOULDER, Colorado, Jan. 19, 2021 /PRNewswire/ -- InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its VaxArray® Measles and Rubella (MR) antigen qu...

2021-01-19 16:00 1425

Neurophth and AAVnerGene Enter Strategic AAV Capsids Partnership for Next-Generation Ophthalmic Gene Therapy

WUHAN, China and NEWARK, DE., Jan. 19, 2021 /PRNewswire/ -- Neurophth Therapeutics, Inc., a subsidiary of Wuhan Neurophth Biotechnology Ltd. gene therapy company (hereafter Neurophth), and AAVnerGene Inc., a specializing AAV technology company, today announced a strategic partnership to provide ...

2021-01-19 14:05 1850
1 ... 842843844845846847848 ... 859

Week's Top Stories